Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease

Open access
Smith, J. Gustav, Gerszten, Robert E. · 2017 · Circulation

Abstract

Plasma biomarkers that reflect molecular states of the cardiovascular system are central for clinical decision making. Routinely used plasma biomarkers include troponins, natriuretic peptides, and lipoprotein particles, yet interrogate only a modest subset of pathways relevant to cardiovascular disease. Systematic profiling of a larger portion of circulating plasma proteins (the plasma proteome) will provide opportunities for unbiased discovery of novel markers to improve diagnostic or predictive accuracy. In addition, proteomic profiling may inform pathophysiological understanding and point to novel therapeutic targets. Obstacles for comprehensive proteomic profiling include the immense size and structural heterogeneity of the proteome, and the broad range of abundance levels, as well. Proteome-wide, untargeted profiling can be performed in tissues and cells with tandem mass spectrometry. However, applications to plasma are limited by the need for complex preanalytical sample preparation stages limiting sample throughput. Multiplexing of targeted methods based on capture and detection of specific proteins are therefore receiving increasing attention in plasma proteomics. Immunoaffinity assays are the workhorse for measuring individual proteins but have been limited for proteomic applications by long development times, cross-reactivity preventing multiplexing, specificity issues, and incomplete sensitivity to detect proteins in the lower range of the abundance spectrum (below picograms per milliliter). Emerging technologies to address these issues include nucleotide-labeled immunoassays and aptamer reagents that can be automated for efficient multiplexing of thousands of proteins at high sample throughput, coupling of affinity capture methods to mass spectrometry for improved specificity, and ultrasensitive detection systems to measure low-abundance proteins. In addition, proteomics can now be integrated with modern genomics tools to comprehensively relate proteomic profiles to genetic variants, which may both influence binding of affinity reagents and serve to validate the target specificity of affinity assays. The application of deep quantitative proteomic profiling to large cohorts has thus become increasingly feasible with emerging affinity methods. The aims of this article are to provide the broad readership of Circulation with a timely overview of emerging methods for affinity proteomics and recent progress in cardiovascular medicine based on such methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.116.025446

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 79

  1. 10.1161/CIR.0000000000000152 · DOI · Paper page
  2. 10.1002/pmic.200500140 · DOI
  3. 10.1161/CIRCRESAHA.110.225003 · DOI
  4. 10.1042/bj0310313 · DOI
  5. 10.1073/pnas.74.12.5421 · DOI · Paper page
  6. Putnam FW. The Plasma Proteins. 2nd ed. New York, NY: Academic Press; 1975.
  7. 10.1002/pmic.200500358 · DOI · Paper page
  8. 10.1038/nbt1183 · DOI · Paper page
  9. 10.1074/mcp.M300127-MCP200 · DOI · Paper page
  10. 10.1074/mcp.M110.006353 · DOI · Paper page
  11. 10.1126/science.1260419 · DOI · Paper page
  12. 10.1021/pr300924j · DOI
  13. 10.1152/ajplung.00044.2008 · DOI
  14. 10.1038/nmeth.2518 · DOI · Paper page
  15. 10.1074/mcp.M111.014423 · DOI · Paper page
  16. 10.1038/nprot.2013.120 · DOI · Paper page
  17. 10.1161/CIRCULATIONAHA.112.096388 · DOI
  18. 10.1002/pmic.201300334 · DOI
  19. 10.1373/clinchem.2009.126706 · DOI · Paper page
  20. 10.1016/0019-2791(71)90454-X · DOI · Paper page
  21. 10.1016/0014-5793(71)80319-8 · DOI · Paper page
  22. 10.1016/j.jacc.2012.08.969 · DOI · Paper page
  23. 10.1093/eurheartj/ehq509 · DOI · Paper page
  24. Clinical and Laboratory Standard Institute. Protocols for Determination of Limits of Detection and Limits of Quantitation: Approved Guideline. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2004. CLSI publication EP17-A.
  25. 10.1373/clinchem.2009.127514 · DOI · Paper page
  26. 10.1016/S0091-679X(08)60556-7 · doi:10.1016/s0091-679x(08)60556-7
  27. 10.1038/ng1037 · DOI · Paper page
  28. 10.1515/cclm-2014-0565 · DOI
  29. 10.1056/NEJMoa0903515 · DOI · Paper page
  30. 10.1056/NEJMoa0900428 · DOI · Paper page
  31. 10.1373/clinchem.2009.132654 · DOI · Paper page
  32. 10.1016/j.jacc.2014.03.017 · DOI · Paper page
  33. 10.1021/ac3027178 · DOI · Paper page
  34. 10.1039/c6an00059b · DOI
  35. 10.1039/c3lc50477h · DOI · Paper page
  36. 10.1373/clinchem.2007.091181 · DOI · Paper page
  37. 10.1373/clinchem.2011.179176 · DOI
  38. 10.1093/eurheartj/ehn504 · DOI · Paper page
  39. 10.1373/clinchem.2015.242081 · doi:10.1373/clinchem.2015.242081
  40. 10.1038/nbt.1641 · DOI · Paper page
  41. 10.1016/j.jim.2015.04.017 · DOI
  42. 10.1373/clinchem.2009.135087 · DOI · Paper page
  43. 10.1002/smll.201302709 · DOI
  44. 10.1126/science.1439758 · DOI · Paper page
  45. 10.1038/nbt0502-473 · DOI · Paper page
  46. 10.1093/nar/gkr424 · DOI · Paper page
  47. 10.1002/prca.201300060 · DOI
  48. 10.1586/epr.12.34 · DOI
  49. 10.1038/nbt1127 · DOI · Paper page
  50. 10.1042/BJ20101860 · DOI · Paper page
  51. 10.1038/nbt0897-772 · DOI · Paper page
  52. 10.1146/annurev-pharmtox-010611-134654 · DOI · Paper page
  53. 10.1073/pnas.0501208102 · doi:10.1073/pnas.0501208102
  54. 10.1126/science.2200121 · DOI · Paper page
  55. 10.1038/346818a0 · DOI · Paper page
  56. 10.1038/mtna.2014.49 · DOI · Paper page
  57. 10.1016/j.euprot.2014.02.002 · DOI · Paper page
  58. 10.1161/CIRCRESAHA.116.308391 · DOI · Paper page
  59. 10.1016/j.cmet.2016.05.023 · DOI · Paper page
  60. 10.1161/CIRCULATIONAHA.116.021803 · DOI · Paper page
  61. 10.1073/pnas.1507719112 · DOI · Paper page
  62. 10.1038/nmeth.3472 · DOI
  63. 10.1074/mcp.M114.046813 · DOI · Paper page
  64. 10.1038/nmeth.2378 · DOI · Paper page
  65. 10.1021/pr034086h · DOI · Paper page
  66. 10.1074/mcp.M500331-MCP200 · DOI · Paper page
  67. 10.1038/ng.328 · DOI · Paper page
  68. 10.1038/ncomms5684 · DOI · Paper page
  69. 10.1007/978-1-60761-247-6_14 · DOI
  70. 10.1172/JCI115855 · DOI · Paper page
  71. 10.1093/hmg/dds186 · DOI
  72. 10.1161/CIRCGENETICS.112.963058 · DOI
  73. 10.1016/j.jacc.2009.11.097 · DOI
  74. 10.1126/science.aaa8332 · DOI · Paper page
  75. 10.1128/MCB.19.3.1720 · DOI · Paper page
  76. 10.1093/eurheartj/ehv385 · DOI
  77. 10.1001/jama.2016.5951 · DOI · Paper page
  78. 10.1016/j.atherosclerosis.2015.07.023 · DOI
  79. 10.1161/STROKEAHA.115.010829 · DOI

Cited by

See all 206

Metadata

Authors
Smith, J. G., & Gerszten, R. E.
Venue
Circulation
Published
2017-04-25
Volume
135
Issue
17
Pages
1651-1664
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2608535836
Cited by
206
References
20
FWCI
7.42
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. https://app.cochat.ai/papers/10.1161/circulationaha.116.025446
The paper
Smith, J. G., & Gerszten, R. E. (2017). Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Circulation. https://doi.org/10.1161/circulationaha.116.025446

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.